|
|
||||||||
Administration of the trypanocidal drug, Benznidazole (N-benzyl-2-nitroimidazoleacetamide) to Trypanosoma cruzi-infected rabbits did not arrest the destructive Chagas' heart myocarditis. A typical feature of lymphocytic infiltrates associated with non-parasitized heart cell lysis was present in both treated and untreated groups of rabbits. Benznidazole-treated rabbits had their survival time shortened, probably as a consequence of Chagas' heart disease and of the development of lymphomas. The survival time of untreated T. cruzi-infected rabbits was 765 ± 639 days and those treated with Benznidazole in the chronic phase of infection survived for 392 ± 571 days. Malignant, non-Hodgkin's lymphomas were present in 38% of the rabbits that received the nitroarene therapy. Testicular atrophy was observed in 2 out of 10 nitroarene-treated rabbits. Benznidazole administration caused severe cell-mediated immunosuppression in T. cruzi-infected and BCG-immunized rabbits. Specific antibodies against the parasite and an unrelated antigen were detected in high levels, regardless of the nitroarene administration.
This article has been cited by other articles:
![]() |
C. Bern, S. P. Montgomery, B. L. Herwaldt, A. Rassi Jr, J. A. Marin-Neto, R. O. Dantas, J. H. Maguire, H. Acquatella, C. Morillo, L. V. Kirchhoff, et al. Evaluation and Treatment of Chagas Disease in the United States: A Systematic Review JAMA, November 14, 2007; 298(18): 2171 - 2181. [Abstract] [Full Text] [PDF] |
||||
![]() |
A R L Teixeira, N Nitz, M C Guimaro, C Gomes, and C A Santos-Buch Chagas disease Postgrad. Med. J., December 1, 2006; 82(974): 788 - 798. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A Castro, M. M. deMecca, and L. C Bartel Toxic Side Effects of Drugs Used to Treat Chagas' Disease (American Trypanosomiasis) Human and Experimental Toxicology, August 1, 2006; 25(8): 471 - 479. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |